Ticker
VNDACompany Name
VANDA PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Asset Turnover | Revenues |
---|---|---|---|
6/30/2025 | $ 624.75M | 0.33 | $ 203.47M |
3/31/2025 | $ 631.94M | 0.32 | $ 201.35M |
12/31/2024 | $ 656.2M | 0.3 | $ 198.77M |
9/30/2024 | $ 645.12M | 0.3 | $ 190.86M |
6/30/2024 | $ 651.37M | 0.28 | $ 182.02M |
3/31/2024 | $ 652.68M | 0.27 | $ 177.6M |
12/31/2023 | $ 648.44M | 0.3 | $ 192.64M |
9/30/2023 | $ 641.61M | 0.33 | $ 211.85M |
6/30/2023 | $ 641.68M | 0.37 | $ 238.35M |
3/31/2023 | $ 644.53M | 0.4 | $ 256.69M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Revenues / Assets
(=) Asset Turnover
Asset Turnover for VANDA PHARMACEUTICALS INC is calculated as follows: Revenues [ $ 241.44M ] / Assets [ $ 515.9M ]
(=) Asset Turnover [ 0.47 ]
Minimum
Mar 31, 2024
Maximum
Sep 30, 2020
Average
Median
filtered constituents | 4.17K |
---|---|
min | -0.79 |
max | 2.36 |
average | 0.53 |
median | 0.4 |
std | 0.52 |